Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Dermatology Drugs for Children-U.S. Food and Drug Administration Perspective.
Journal: Dermatologic clinics
Published: June 24, 2022
Model-Informed Drug Development Approach Supporting Approval of Adalimumab (HUMIRA) in Adolescent Patients with Hidradenitis Suppurativa: a Regulatory Perspective.
Journal: The AAPS journal
Published: June 22, 2019
Showing 1-2 of 2
Last Updated: 09/26/2026